Polynucleotide Skin Treatments: Evidence, Limits, and Consultation Questions
Polynucleotide skin treatments—often marketed as PN, PDRN, or “salmon DNA” injections—have become a prominent aesthetic trend. The appeal is easy to understand: rather than promising the volume of a filler or the muscle relaxation of a neuromodulator, these products are promoted as a way to improve skin quality.
The terminology, evidence, and regulation are less simple. PN and PDRN are related DNA-derived materials, but the names are not consistently used. Products also vary by formulation, concentration, source, and intended use. Here is a practical framework for evaluating the trend without treating marketing claims as established results.
What are polynucleotide skin treatments?
Polynucleotides are chains made from nucleotide building blocks. In aesthetics, PN and polydeoxyribonucleotide (PDRN) products are commonly discussed as “biostimulatory” or “regenerative” treatments. A 2025 scientific review noted that PN and PDRN are often used interchangeably even though molecular size and formulation can differ. That ambiguity matters: evidence about one preparation should not automatically be applied to every product carrying a similar label.
These treatments are usually discussed in relation to skin texture, elasticity, fine lines, and hydration. Commonly marketed areas include the face, neck, and delicate under-eye skin. The exact method may involve a series of small injections, but protocols are not standardized across products or countries.
They are not the same as:
- Hyaluronic acid filler, which is primarily used to add or redistribute volume
- Neuromodulators, which temporarily reduce selected muscle activity
- PRP or PRF, which are prepared from a person’s own blood
- Topical serums, which do not have the same delivery route as injections
“Skin booster” is a marketing category rather than one uniform substance, so always ask what the actual product contains.
What does the evidence currently show?
The most useful answer is: early findings are encouraging, but confidence is limited.
A systematic review published in 2025 identified nine studies involving 219 patients. It reported promising findings for wrinkles, skin texture, and elasticity, with generally mild, temporary reported side effects. However, the included evidence was rated low to moderate quality, and studies varied in injection area and technique. The authors called for larger, more rigorous research to establish effectiveness, safety, and optimal use.
That means a study showing improvement under specific conditions is not proof that every PN-branded treatment will produce the same change. Small samples, different measurement methods, short follow-up, and product variation can all limit how broadly results apply.
Useful questions about an impressive claim include:
- Was the finding from a randomized controlled trial or a small uncontrolled series?
- Was improvement measured by blinded evaluators, an instrument, or satisfaction alone?
- Which exact product, dose, technique, and treatment area were studied?
- How long were participants followed?
- Were adverse events actively tracked?
Patient satisfaction can be valuable, but it is not interchangeable with objective evidence or long-term safety data.
PN versus PDRN: why the label matters
Both terms refer to DNA-derived biopolymers, yet the scientific literature does not use them consistently. One recent narrative review highlighted wide variation in molecular weight and proposed clearer naming based on molecular structure. That proposal is not a universal regulatory standard, but it illustrates why a generic phrase such as “polynucleotide treatment” may conceal meaningful differences.
Before comparing clinics or prices, request the exact brand and product name. Then ask whether evidence cited by the provider studied that same formulation and the same treatment area. A brochure about a broad ingredient family is not equivalent to product-specific clinical evidence.
Source is another reasonable topic. Some products are derived from purified fish DNA, so people with relevant allergies or dietary, ethical, or religious concerns may want explicit information about origin and manufacturing. A qualified clinician should review the product information and personal health history rather than assuming suitability from a trend name.
How do polynucleotides compare with other options?
A consultation should begin with the concern, not a fashionable product.
Polynucleotides versus hyaluronic acid filler
PN treatments are generally marketed around skin quality, while filler is designed to create structural or volumizing effects depending on product and placement. They are not direct substitutes. Under-eye concerns, for example, can reflect pigmentation, skin texture, shadowing, anatomy, fluid retention, or a combination—so the same treatment will not address every cause.
Polynucleotides versus PRP or PRF
PRP and PRF use components prepared from the patient’s blood; PN/PDRN products are manufactured materials. Preparation, evidence, handling, and regulatory categories differ. Calling both approaches “regenerative” does not make their risks or expected effects identical.
Polynucleotides versus energy-based treatments
Laser, radiofrequency, and ultrasound devices use energy to target tissue. Their downtime, risks, suitability across skin tones, and evidence vary by device and settings. A product injection and an energy-based treatment should be compared by the specific concern, evidence, risk profile, and realistic endpoint—not by which one is newest.
You can browse more neutral overviews in the aesthetic trends and procedures guide.
Safety and regulatory questions to ask
An injection is still a medical procedure even when the marketing language emphasizes glow or hydration. Temporary redness, swelling, tenderness, or bruising may be discussed, but the relevant risk profile depends on the exact product, injection site, technique, and patient.
Regulatory status can also differ between countries and between products. Do not interpret “used in Europe,” “CE marked,” “registered,” or “made in an FDA-registered facility” as automatically meaning the exact product is FDA-approved for the proposed injection and indication in the United States. Ask the clinician to state the status precisely and verify claims through the relevant national regulator.
Bring these questions to a consultation:
- What is the exact product and manufacturer?
- Is it authorized or approved for this route, area, and purpose where I live?
- What evidence supports this exact formulation?
- Who will perform the injections, and what are their credentials?
- What side effects and uncommon complications are documented?
- How are complications recognized and managed?
- What total treatment course, maintenance, and cost are being proposed?
- What alternatives—including doing nothing—fit the same concern?
- Are there reasons this treatment may be unsuitable for me?
Seek a properly licensed clinician working in an appropriate medical setting. For surgical questions or when comparing a nonsurgical trend with surgery, candidacy, risks, recovery, and treatment decisions require an in-person consultation with a qualified board-certified plastic surgeon.
Set realistic expectations before using visual tools
Skin-quality changes can be subtle and affected by lighting, camera processing, hydration, makeup, and expression. Standardized photographs are more useful than dramatic social-media comparisons: use the same camera, distance, angle, lighting, and facial expression.
AI previews can help someone explore aesthetic ideas and communicate preferences, but they are illustrative entertainment and consultation aids—not surgical simulations, treatment predictions, or guaranteed outcomes. Tools on Try Plastic Surgery may be useful for visual exploration, while the actual possibilities and limitations must come from a qualified clinician examining the person and discussing the specific product or procedure.
The bottom line
Polynucleotide skin treatments are an interesting, fast-growing category with promising early research, not a settled one-size-fits-all solution. The strongest approach is to look past the umbrella label: identify the exact formulation, check its regulatory status, examine product-specific evidence, and compare it with alternatives based on a clearly defined concern.
No one needs an aesthetic treatment to look valid or confident. If you are considering one, use a licensed, appropriately qualified clinician and make decisions after a balanced discussion of limits, risks, costs, and the option not to proceed.
